Cargando…

Colorectal cancer screenings: a single center experience

AIM: evaluating the impact of screening programmes on colorectal cancer (CRC) in Italy. METHODS: we studied 1292 patients with colorectal cancer. Data were collected from January 2004 through December 2015 in Parma University Hospital. We compared clinophatological features to evaluate the real impa...

Descripción completa

Detalles Bibliográficos
Autores principales: Viani, Lorenzo, Dell’Abate, Paolo, Del Rio, Paolo, Marchesi, Federico, Tartamella, Francesco, Rossini, Matteo, Bertocchi, Elisa, Giuffrida, Mario
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mattioli 1885 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927528/
https://www.ncbi.nlm.nih.gov/pubmed/33525283
http://dx.doi.org/10.23750/abm.v91i4.8386
_version_ 1783659689030975488
author Viani, Lorenzo
Dell’Abate, Paolo
Del Rio, Paolo
Marchesi, Federico
Tartamella, Francesco
Rossini, Matteo
Bertocchi, Elisa
Giuffrida, Mario
author_facet Viani, Lorenzo
Dell’Abate, Paolo
Del Rio, Paolo
Marchesi, Federico
Tartamella, Francesco
Rossini, Matteo
Bertocchi, Elisa
Giuffrida, Mario
author_sort Viani, Lorenzo
collection PubMed
description AIM: evaluating the impact of screening programmes on colorectal cancer (CRC) in Italy. METHODS: we studied 1292 patients with colorectal cancer. Data were collected from January 2004 through December 2015 in Parma University Hospital. We compared clinophatological features to evaluate the real impact of screening programmes on detecting early stage colorectal cancers in target population. RESULTS: screening programmes with fecal occult blood test (FOBT) and colonoscopy covered only patients from 50 to 69. In our study we reported that the 52,3% of patients with CRC were over 70 and out of screen time, while only 47,7% were under 70. Early detection seems to be related to early stage of CRC and to an improved overall survival. CONCLUSION: The importance of early detection in colorectal cancers represents the most important outcome for OS. The risk of colorectal cancer is increased in elderly. Actual screening programmes cover less than 50% of population with colorectal cancer. Screening should be considered for patients over 70, due to the high number of new diagnosis in symptomatic disease and worst prognosis, in accordance with advanced cancer stage and comorbidities in elderly. (www.actabiomedica.it)
format Online
Article
Text
id pubmed-7927528
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Mattioli 1885
record_format MEDLINE/PubMed
spelling pubmed-79275282021-03-04 Colorectal cancer screenings: a single center experience Viani, Lorenzo Dell’Abate, Paolo Del Rio, Paolo Marchesi, Federico Tartamella, Francesco Rossini, Matteo Bertocchi, Elisa Giuffrida, Mario Acta Biomed Original Article AIM: evaluating the impact of screening programmes on colorectal cancer (CRC) in Italy. METHODS: we studied 1292 patients with colorectal cancer. Data were collected from January 2004 through December 2015 in Parma University Hospital. We compared clinophatological features to evaluate the real impact of screening programmes on detecting early stage colorectal cancers in target population. RESULTS: screening programmes with fecal occult blood test (FOBT) and colonoscopy covered only patients from 50 to 69. In our study we reported that the 52,3% of patients with CRC were over 70 and out of screen time, while only 47,7% were under 70. Early detection seems to be related to early stage of CRC and to an improved overall survival. CONCLUSION: The importance of early detection in colorectal cancers represents the most important outcome for OS. The risk of colorectal cancer is increased in elderly. Actual screening programmes cover less than 50% of population with colorectal cancer. Screening should be considered for patients over 70, due to the high number of new diagnosis in symptomatic disease and worst prognosis, in accordance with advanced cancer stage and comorbidities in elderly. (www.actabiomedica.it) Mattioli 1885 2020 2020-11-10 /pmc/articles/PMC7927528/ /pubmed/33525283 http://dx.doi.org/10.23750/abm.v91i4.8386 Text en Copyright: © 2020 ACTA BIO MEDICA SOCIETY OF MEDICINE AND NATURAL SCIENCES OF PARMA http://creativecommons.org/licenses/by-nc-sa/4.0 This work is licensed under a Creative Commons Attribution 4.0 International License
spellingShingle Original Article
Viani, Lorenzo
Dell’Abate, Paolo
Del Rio, Paolo
Marchesi, Federico
Tartamella, Francesco
Rossini, Matteo
Bertocchi, Elisa
Giuffrida, Mario
Colorectal cancer screenings: a single center experience
title Colorectal cancer screenings: a single center experience
title_full Colorectal cancer screenings: a single center experience
title_fullStr Colorectal cancer screenings: a single center experience
title_full_unstemmed Colorectal cancer screenings: a single center experience
title_short Colorectal cancer screenings: a single center experience
title_sort colorectal cancer screenings: a single center experience
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7927528/
https://www.ncbi.nlm.nih.gov/pubmed/33525283
http://dx.doi.org/10.23750/abm.v91i4.8386
work_keys_str_mv AT vianilorenzo colorectalcancerscreeningsasinglecenterexperience
AT dellabatepaolo colorectalcancerscreeningsasinglecenterexperience
AT delriopaolo colorectalcancerscreeningsasinglecenterexperience
AT marchesifederico colorectalcancerscreeningsasinglecenterexperience
AT tartamellafrancesco colorectalcancerscreeningsasinglecenterexperience
AT rossinimatteo colorectalcancerscreeningsasinglecenterexperience
AT bertocchielisa colorectalcancerscreeningsasinglecenterexperience
AT giuffridamario colorectalcancerscreeningsasinglecenterexperience